Suscripción a Biblioteca: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Publicado 6 números por año

ISSN Imprimir: 0743-4863

ISSN En Línea: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Microparticles and Nanoparticles as Delivery Systems for DNA Vaccines

Volumen 20, Edición 2&3, 2003, 36 pages
DOI: 10.1615/CritRevTherDrugCarrierSyst.v20.i23.10
Get accessGet access

SINOPSIS

DNA vaccines, also referred to as genetic vaccines, are generating significant preclinical and clinical interest. It has been proven that the expression of an antigen or antigens from plasmid DNA (pDNA) may elicit both humoral and cellular immune responses. Therefore, DNA vaccines may have potential as new vaccines for important pathogens such as HIV, hepatitis C, tuberculosis, and malaria. However, the clinical results using "naked" pDNA have been disappointing in the breadth and depth of the immune response and the relatively high doses of pDNA needed to elicit a response. Clinical trials with the gene gun have been promising, but it is unclear whether this technology will be commercially viable. As a result, there exists a clear need for new vaccine delivery systems that can be administered at low doses to elicit strong humoral and cellular immune responses. One promising approach is the development of microparticles and nanoparticles as delivery systems for DNA vaccines. In this review, the application of microparticles and nanoparticles as DNA vaccine delivery systems will be critically reviewed with a primary focus on those systems that have generated in vivo immune responses.

CITADO POR
  1. Voltan Rebecca, Castaldello Arianna, Brocca-Cofano Egidio, Altavilla Giuseppe, Caputo Antonella, Laus Michele, Sparnacci Katia, Ensoli Barbara, Spaccasassi Silvia, Ballestri Marco, Tondelli Luisa, Preparation and Characterization of Innovative Protein-coated Poly(Methylmethacrylate) Core-shell Nanoparticles for Vaccine Purposes, Pharmaceutical Research, 24, 10, 2007. Crossref

  2. Epple M., Ganesan K., Heumann R., Klesing J., Kovtun A., Neumann S., Sokolova V., Application of calcium phosphatenanoparticles in biomedicine, J. Mater. Chem., 20, 1, 2010. Crossref

  3. Tang Choon K., Lodding Jodie, Minigo Gabriela, Pouniotis Dodie S., Plebanski Magdalena, Scholzen Anja, McKenzie Ian F. C., Pietersz Geoffrey A., Apostolopoulos Vasso, Mannan-mediated gene delivery for cancer immunotherapy, Immunology, 120, 3, 2007. Crossref

  4. Katz Eugenii, Willner Itamar, Integrierte Hybridsysteme aus Nanopartikeln und Biomolekülen: Synthese, Eigenschaften und Anwendungen, Angewandte Chemie, 116, 45, 2004. Crossref

  5. Grichko Varvara, Grishko Victor, Shenderova Olga, Nanodiamond bullets and their biological targets, NanoBiotechnology, 2, 1-2, 2006. Crossref

  6. Paolino Donatella, Sinha Piyush, Fresta Massimo, Ferrari Mauro, Drug Delivery Systems, in Encyclopedia of Medical Devices and Instrumentation, 2006. Crossref

  7. Mena María, Chanfreau Sébastien, Gimeno Miquel, Bárzana Eduardo, Enzymatic synthesis of poly-l-lactide-co-glycolide in the ionic liquid 1-butyl-3-methylimidazolium hexafluorophosphate, Bioprocess and Biosystems Engineering, 33, 9, 2010. Crossref

  8. Messai Isabelle, Delair Thierry, One-Step Cationic Poly(D,L-lactic acid) Particle Synthesis by Diafiltration and Interactions with Plasmid DNA, Macromolecular Materials and Engineering, 290, 8, 2005. Crossref

  9. Bro�� Pavel, Hunziker Patrick, Nanotechnologies for Targeted Delivery of Drugs, in Nanotechnologies for the Life Sciences, 2007. Crossref

  10. Katz Eugenii, Willner Itamar, Integrated Nanoparticle-Biomolecule Hybrid Systems: Synthesis, Properties, and Applications, Angewandte Chemie International Edition, 43, 45, 2004. Crossref

  11. Wendorf Janet, Singh Manmohan, Chesko James, Kazzaz Jina, Soewanan Elawati, Ugozzoli Mildred, O'Hagan Derek, A Practical Approach to the use of Nanoparticles for Vaccine Delivery, Journal of Pharmaceutical Sciences, 95, 12, 2006. Crossref

  12. Badea Ildiko, Verrall Ronald, Baca-Estrada Maria, Tikoo Suresh, Rosenberg Alan, Kumar Praveen, Foldvari Marianna, In vivo cutaneous interferon-γ gene delivery using novel dicationic (gemini) surfactant-plasmid complexes, The Journal of Gene Medicine, 7, 9, 2005. Crossref

  13. Xie Zhao, Li Hui, Chen Jianlin, Zhang Hua-bing, Wang Ying-Yu, Chen Qian, Zhao Zhong-Zhong, Cheng Chi, Zhang Huan, Yang Yi, Wang Hong-Ning, Gao Rong, Shuffling of pig interleukin-2 gene and its enhancing of immunity in mice to Pasteurella multocida vaccine, Vaccine, 25, 48, 2007. Crossref

  14. Maitra Amarnath, Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy, Expert Review of Molecular Diagnostics, 5, 6, 2005. Crossref

  15. Klausner Eytan A., Peer Dan, Chapman Robert L., Multack Richard F., Andurkar Shridhar V., Corneal gene therapy, Journal of Controlled Release, 124, 3, 2007. Crossref

  16. Messai Isabelle, Lamalle Delphine, Munier Séverine, Verrier Bernard, Ataman-Önal Yasemin, Delair Thierry, Poly(d,l-lactic acid) and chitosan complexes: interactions with plasmid DNA, Colloids and Surfaces A: Physicochemical and Engineering Aspects, 255, 1-3, 2005. Crossref

  17. Bisht Savita, Bhakta Gajadhar, Mitra Susmita, Maitra Amarnath, pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery, International Journal of Pharmaceutics, 288, 1, 2005. Crossref

  18. Jain Anekant, Yan Weili, Miller Keith R., O’Carra Ronan, Woodward Jerold G., Mumper Russell J., Tresyl-based conjugation of protein antigen to lipid nanoparticles increases antigen immunogenicity, International Journal of Pharmaceutics, 401, 1-2, 2010. Crossref

  19. Sahoo S.K., Parveen S., Panda J.J., The present and future of nanotechnology in human health care, Nanomedicine: Nanotechnology, Biology and Medicine, 3, 1, 2007. Crossref

  20. Tian Huayu, Tang Zhaohui, Zhuang Xiuli, Chen Xuesi, Jing Xiabin, Biodegradable synthetic polymers: Preparation, functionalization and biomedical application, Progress in Polymer Science, 37, 2, 2012. Crossref

  21. Salman Hesham H., Gamazo Carlos, Campanero Miguel A., Irache Juan M., Salmonella-like bioadhesive nanoparticles, Journal of Controlled Release, 106, 1-2, 2005. Crossref

  22. Singh Manmohan, Chakrapani Aravind, O’Hagan Derek, Nanoparticles and microparticles as vaccine-delivery systems, Expert Review of Vaccines, 6, 5, 2007. Crossref

  23. Li Xinran, Sloat Brian R., Yanasarn Nijaporn, Cui Zhengrong, Relationship between the size of nanoparticles and their adjuvant activity: Data from a study with an improved experimental design, European Journal of Pharmaceutics and Biopharmaceutics, 78, 1, 2011. Crossref

  24. Smitha S., Mukundan P., Krishna Pillai P., Warrier K.G.K., Silica–gelatin bio-hybrid and transparent nano-coatings through sol–gel technique, Materials Chemistry and Physics, 103, 2-3, 2007. Crossref

  25. Fuller Deborah H., Loudon Peter, Schmaljohn Connie, Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases, Methods, 40, 1, 2006. Crossref

  26. Sinyakov Michael S., Dror Moti, Lublin-Tennenbaum Tammy, Salzberg Samuel, Margel Shlomo, Avtalion Ramy R., Nano- and microparticles as adjuvants in vaccine design: Success and failure is related to host natural antibodies, Vaccine, 24, 42-43, 2006. Crossref

  27. Munier Séverine, Messai Isabelle, Delair Thierry, Verrier Bernard, Ataman-Önal Yasemin, Cationic PLA nanoparticles for DNA delivery: Comparison of three surface polycations for DNA binding, protection and transfection properties, Colloids and Surfaces B: Biointerfaces, 43, 3-4, 2005. Crossref

  28. Jo Jun-ichiro, Tabata Yasuhiko, Non-viral gene transfection technologies for genetic engineering of stem cells, European Journal of Pharmaceutics and Biopharmaceutics, 68, 1, 2008. Crossref

  29. Greenland John R., Letvin Norman L., Chemical adjuvants for plasmid DNA vaccines, Vaccine, 25, 19, 2007. Crossref

  30. Matic S., Minafra A., Boscia D., da Cunha A.T.P., Martelli G.P., Production of antibodies to Little cherry virus 1 coat protein by DNA prime and protein boost immunization, Journal of Virological Methods, 155, 1, 2009. Crossref

  31. Poulsen Allan K., Arleth Lise, Almdal Kristoffer, Scharff-Poulsen Anne Marie, Unusually large acrylamide induced effect on the droplet size in AOT/Brij30 water-in-oil microemulsions, Journal of Colloid and Interface Science, 306, 1, 2007. Crossref

  32. Zhang Hua-Bing, Wan Xiao-Ping, Bai Guang-Ming, Gao Lin-Feng, Chen Chi, Zhang Huang, Lv Xue-Bing, Wang Ze-Zhou, Li Jiang-Ling, Gao Rong, Improvement Of The Immunity Of Piglets To PRRS Vaccine By A Porcine IL-4 And IL-6 Fusion Gene Encapsulated In Chitosan Nanoparticles, Procedia in Vaccinology, 6, 2012. Crossref

  33. Zheng Ying, Kovacs Jeffrey R., Gawalt Ellen S., Shen Hongmei, Meng Wilson S., Characterization of particles fabricated with poly(D,L-lactic-co-glycolic acid) and an ornithine–histidine peptide as carriers of oligodeoxynucleotide for delivery into primary dendritic cells, Journal of Biomaterials Science, Polymer Edition, 17, 12, 2006. Crossref

  34. DENKBAŞ EMIR B., VASEASHTA A., NANOTECHNOLOGY IN MEDICINE AND HEALTH SCIENCES, Nano, 03, 04, 2008. Crossref

  35. Tafalla Carolina, Bøgwald Jarl, Dalmo Roy A., Adjuvants and immunostimulants in fish vaccines: Current knowledge and future perspectives, Fish & Shellfish Immunology, 35, 6, 2013. Crossref

  36. Wu Qinge, Du Fang, Luo Yu, Lu Wei, Huang Jin, Yu Jiahui, Liu Shiyuan, Poly(ethylene glycol) shell-sheddable nanomicelle prodrug of camptothecin with enhanced cellular uptake, Colloids and Surfaces B: Biointerfaces, 105, 2013. Crossref

  37. Tafalla Carolina, Bøgwald Jarl, Dalmo Roy A., Munang'andu Hetron Mweemba, Evensen Øystein, Adjuvants in Fish Vaccines, in Fish Vaccination, 2014. Crossref

  38. He Pan, Takeshima Shin-nosuke, Tada Seiichi, Akaike Toshihiro, Ito Yoshihiro, Aida Yoko, pH-sensitive carbonate apatite nanoparticles as DNA vaccine carriers enhance humoral and cellular immunity, Vaccine, 32, 47, 2014. Crossref

  39. Lanao José M., Briones Elsa, Colino Clara I., Recent advances in delivery systems for anti-HIV1 therapy, Journal of Drug Targeting, 15, 1, 2007. Crossref

  40. Lala Sanchaita, Pramanick Swapan, Mukhopadhyay Sibabrata, Bandyopadhyay Santu, Basu Mukul Kumar, Harmine: Evaluation of its Antileishmanial Properties in Various Vesicular Delivery Systems, Journal of Drug Targeting, 12, 3, 2004. Crossref

  41. Lala Sanchaita, Gupta Syamasri, Sahu Niranjan P., Mandal Debayan, Mondal Nirup B., Moulik Satya P., Basu Mukul K., Critical evaluation of the therapeutic potential of bassic acid incorporated in oil-in-water microemulsions and poly-d,l-lactide nanoparticles against experimental leishmaniasis, Journal of Drug Targeting, 14, 4, 2006. Crossref

  42. Literature Alerts, Journal of Microencapsulation, 21, 3, 2004. Crossref

  43. Tiptiri-Kourpeti Angeliki, Spyridopoulou Katerina, Pappa Aglaia, Chlichlia Katerina, DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy, Pharmacology & Therapeutics, 165, 2016. Crossref

  44. Poecheim Johanna, Barnier-Quer Christophe, Collin Nicolas, Borchard Gerrit, Ag85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune Responses, Vaccines, 4, 3, 2016. Crossref

  45. Dalmo Roy, Bøgwald Jarl, Tafalla Carolina, Adjuvants and Delivery Methods: Current and Novel, in Fish Vaccines, 2016. Crossref

  46. Kaul Goldie, Amiji Mansoor, Biodistribution and Targeting Potential of Poly(ethylene glycol)-modified Gelatin Nanoparticles in Subcutaneous Murine Tumor Model, Journal of Drug Targeting, 12, 9-10, 2004. Crossref

  47. Shan Songhua, Fenwick Stan, Ellis Trevor, Poinern Eddy, Edwards John, Le Xuan, Jiang Zhongtao, Evaluation of different chemical adjuvants on an avian influenza H6 DNA vaccine in chickens, Avian Pathology, 45, 6, 2016. Crossref

  48. Xu Menglu, Chen Yulin, Banerjee Parikshit, Zong Li, Jiang Lei, Dendritic Cells Targeting and pH-Responsive Multi-layered Nanocomplexes for Smart Delivery of DNA Vaccines, AAPS PharmSciTech, 18, 7, 2017. Crossref

  49. Kumar Amit, Xu Yuehong, Cui Zhengrong, Cutaneous DNA Immunization: Enhancing Penetration by Hair Follicle Modification or Microneedle Application, in Percutaneous Penetration Enhancers Physical Methods in Penetration Enhancement, 2017. Crossref

  50. Chen Yi, Song Tingyu, Xiao Yong-Le, Wan Xiaoping, Yang Luyi, Li Jinghai, Zeng Guangzhi, Fang Pengfei, Wang Ze-Zhou, Gao Rong, Enhancement of immune response of piglets to PCV-2 vaccine by porcine IL-2 and fusion IL-4/6 gene entrapped in chitosan nanoparticles, Research in Veterinary Science, 117, 2018. Crossref

  51. Sahoo S. K., Parveen S., Panda J. J., Chapter 32: The Present and Future of Nanotechnology in Human Health Care, in Nanomedicine in Cancer, 2017. Crossref

  52. Vincent Abhilash, Babu Suresh, Heckert Eric, Dowding Janet, Hirst Suzanne M., Inerbaev Talgat M., Self William T., Reilly Christopher M., Masunov Artëm E., Rahman Talat S., Seal Sudipta, Protonated Nanoparticle Surface Governing Ligand Tethering and Cellular Targeting, ACS Nano, 3, 5, 2009. Crossref

  53. Moghimi S. Moein, Hunter A. Christy, Murray J. Clifford, Nanomedicine: current status and future prospects, The FASEB Journal, 19, 3, 2005. Crossref

  54. Bassi Matteo, Santinello Irene, Bevilacqua Andrea, Bassi Pierfrancesco, Nanotechnology: A Big Revolution from the Small World, Urologia Journal, 80, 1, 2013. Crossref

  55. Vaseashta A., Nanoscale Materials, Devices, and Systems for Chem.-Bio Sensors, Photonics, and Energy Generation and Storage, in Functionalized Nanoscale Materials, Devices and Systems, 2008. Crossref

  56. Goyal Amit K., Rath Goutam, Garg Tarun, Nanotechnological Approaches for Genetic Immunization, in DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases, 2013. Crossref

  57. Mazda Osam, Kishida Tsunao, Functional Nucleotide Sequences Capable of Promoting Non-viral Genetic Transfer, in Non-viral Gene Therapy, 2005. Crossref

  58. Perera Glen, Bernkop-Schnürch Andreas, Pharmaceutical Non-Viral Formulations for Gene Vaccines, in Gene Vaccines, 2012. Crossref

  59. Manthorpe Marston, Hobart Peter, Hermanson Gary, Ferrari Marilyn, Geall Andrew, Goff Blake, Rolland Alain, Plasmid Vaccines and Therapeutics: From Design to Applications, in Gene Therapy and Gene Delivery Systems, 99, 2005. Crossref

  60. Kaminski Robert W., Turbyfill K. Ross, Chao C., Ching W. M., Oaks Edwin V., Mucosal Adjuvanticity of a Shigella Invasin Complex with DNA-Based Vaccines , Clinical and Vaccine Immunology, 16, 4, 2009. Crossref

  61. Chacon O., Bannantine J.P., DNA Vaccines Against Tuberculosis, in Mycobacterium Bovis Infection in Animals and Humans, 2006. Crossref

  62. Hazarika Hemanga, Krishnatreyya Harshita, Chattopadhyay Pronobesh, Saha Achintya, Pathak Yashwant V., Zaman Md Kamaruz, Nanoemulsion Delivery of Herbal Products: Prospects and Challenges, in Nano Medicine and Nano Safety, 2020. Crossref

  63. Olsen Hannah E, Lynn Geoffrey M, Valdes Pablo A, Cerecedo Lopez Christian D, Ishizuka Andrew S, Arnaout Omar, Bi W Linda, Peruzzi Pier Paolo, Chiocca E Antonio, Friedman Gregory K, Bernstock Joshua D, Therapeutic cancer vaccines for pediatric malignancies: advances, challenges, and emerging technologies, Neuro-Oncology Advances, 3, 1, 2021. Crossref

  64. Chen Liben, Li Shuang, Wang Zhengfang, Chang Ruilong, Su Jingliang, Han Bo, Protective effect of recombinant staphylococcal enterotoxin A entrapped in polylactic-co-glycolic acid microspheres against Staphylococcus aureus infection, Veterinary Research, 43, 1, 2012. Crossref

  65. de Souza J Brian, Immunization of experimental animals, in eLS, 2006. Crossref

  66. Schmidt Hartley T., Gray Ben L., Wingert Philip A., Ostafin Agnes E., Assembly of Aqueous-Cored Calcium Phosphate Nanoparticles for Drug Delivery, Chemistry of Materials, 16, 24, 2004. Crossref

  67. Pinheiro Marina, Lúcio Marlene, Lima José LFC, Reis Salette, Liposomes as drug delivery systems for the treatment of TB, Nanomedicine, 6, 8, 2011. Crossref

  68. Liang Yan, Cui Lei, Xiao Li, Liu Xiao, Yang Yourong, Ling Yanbo, Wang Tong, Wang Lan, Wang Jie, Wu Xueqiong, Immunotherapeutic Effects of Different Doses of Mycobacterium tuberculosis ag85a/b DNA Vaccine Delivered by Electroporation, Frontiers in Immunology, 13, 2022. Crossref

  69. Gelinas David S., DaSilva Kevin, Fenili Daniela, St. George-Hyslop Peter, McLaurin JoAnne, Immunotherapy for Alzheimer's disease, Proceedings of the National Academy of Sciences, 101, suppl_2, 2004. Crossref

  70. Winstone Nicola, Wilson Aaron J., Morrow Gavin, Boggiano Cesar, Chiuchiolo Maria J., Lopez Mary, Kemelman Marina, Ginsberg Arielle A., Mullen Karl, Coleman John W., Wu Chih-Da, Narpala Sandeep, Ouellette Ian, Dean Hansi J., Lin Feng, Sardesai Niranjan Y., Cassamasa Holly, McBride Dawn, Felber Barbara K., Pavlakis George N., Schultz Alan, Hudgens Michael G., King C. Richter, Zamb Timothy J., Parks Christopher L., McDermott Adrian B., Enhanced Control of Pathogenic Simian Immunodeficiency Virus SIVmac239 Replication in Macaques Immunized with an Interleukin-12 Plasmid and a DNA Prime-Viral Vector Boost Vaccine Regimen, Journal of Virology, 85, 18, 2011. Crossref

  71. Yu Jiahui, Li Xiangyang, Luo Yu, Lu Wei, Huang Jin, Liu Shiyuan, Poly(ethylene glycol) shell-sheddable magnetic nanomicelle as the carrier of doxorubicin with enhanced cellular uptake, Colloids and Surfaces B: Biointerfaces, 107, 2013. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain